A, R., F, D., F, P., C, L., I, T., AR, G., . . . J, K. (2021). Efficacy and tolerability of VCD chemotherapy in a UK real-world dataset of elderly transplant-ineligible newly diagnosed myeloma patients. European journal of haematology, 106(4), 563. https://doi.org/10.1111/ejh.13588
Chicago Style (17th ed.) CitationA, Rampotas, et al. "Efficacy and Tolerability of VCD Chemotherapy in a UK Real-world Dataset of Elderly Transplant-ineligible Newly Diagnosed Myeloma Patients." European Journal of Haematology 106, no. 4 (2021): 563. https://doi.org/10.1111/ejh.13588.
MLA (9th ed.) CitationA, Rampotas, et al. "Efficacy and Tolerability of VCD Chemotherapy in a UK Real-world Dataset of Elderly Transplant-ineligible Newly Diagnosed Myeloma Patients." European Journal of Haematology, vol. 106, no. 4, 2021, p. 563, https://doi.org/10.1111/ejh.13588.